Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of the BÜHLMANN fCAL™ ELISA as an Aid in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome

NCT02351635 is registered in ClinicalTrials.gov with Bühlmann Laboratories AG as lead sponsor.

NCT NCT02351635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02351635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of the BÜHLMANN fCAL™ ELISA as an Aid in the Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome
Lead sponsor
Bühlmann Laboratories AG
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
April 30, 2018
Enrollment
478 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease, irritable bowel syndrome